Mesa Laboratories MLAB

NASDAQ MLAB
$127.42 +2.26 (+1.81%)
As of: Oct 21, 2026 · 10:30 AM EDT

Mesa Laboratories (MLAB) stock price is $127.42, up 1.81% on the day, as of Oct 21, 2026. It has a market cap of $720.81Mn and a P/E ratio of 150.17, and is classified in the Life Sciences Tools industry (Healthcare sector).

Key Stats
Market Cap720.81 Mn
P/E150.17
P/S2.89
Div. Yield0.00
Total Debt (Qtr)142.87 Mn
Revenue Growth (1y) (Qtr)1.00
Add ratio to table…

About

Mesa Laboratories, Inc. is a global provider of life sciences tools and critical quality control solutions for the pharmaceutical healthcare and medical device industries. The company designs manufactures and sells products that help customers ensure product integrity increase patient and worker safety and improve quality of life worldwide. Mesa Laboratories, Inc. generates revenue from the sale of products including consumables and hardware and from the provision of…

Read more ↓
Sector: Healthcare Sector rationale Mesa Laboratories designs and manufactures life sciences tools, genetic analysis tools (Clinical Genomics), and protein analysis systems (Biopharmaceutical Development) sold to pharmaceutical companies, hospitals, and clinical research labs. These activities fall squarely within the Healthcare sector's 'Life Sciences Tools', 'Medical Devices', and 'Contract Research' industries. Industries: Life Sciences Tools Life Sciences Tools Primary Mesa Laboratories designs and manufactures life sciences tools, including the MassARRAY system for genomic testing and Gyrolab systems for protein analysis and peptide synthesis. These products, along with their associated chips, panels, and reagents, are sold to biopharma R&D teams, academic laboratories, and clinical research labs. Medical Supplies Medical Supplies Secondary The Sterilization and Disinfection Control segment manufactures and sells biological and chemical indicators, inoculated carriers, and cleaning consumables used to assess sterilization effectiveness in healthcare and pharmaceutical settings. Diagnostic Equipment Diagnostic Equipment Secondary The company sells clinical diagnostic tools and consumables, such as the MassARRAY system and related reagent solutions, used by reference pathology labs and clinical research labs for inherited disease and oncology testing. Classified using BQ-MICS CIK: 0000724004

Geographical Breakdown of Revenue (2026)

History

Timing of Transfer of Good or Service Breakdown of Revenue (2026)

History
Peer percentiles

How Mesa Laboratories ranks

Ranked against the 248 companies in Medical Devices and Diagnostics58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 151xMedian 28.9x 70th
  • P/FCF 13.5xMedian 26.0x 92nd
  • P/Operating cash flow 12.8xMedian 20.1x 90th
  • P/S 2.86xMedian 3.07x 54th
  • P/B 3.79xMedian 2.40x 36th
  • P/Tangible book 6.48xMedian 3.05x 24th
  • EV/EBITDA 18.2xMedian 18.0x 77th
  • EV/EBIT 36.8xMedian 27.8x 75th
  • EV/Revenue 3.31xMedian 3.25x 48th
  • EV/FCF 15.6xMedian 26.6x 91st
  • EV/Operating cash flow 14.9xMedian 21.9x 88th
  • PEG (3Y EPS CAGR) 4.30Median 0.86 10th
Peer group

Peer Comparison

Companies in the Life Sciences Tools
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 257.88 Bn37.015.5742.55 Bn
2 ABT Abbott Laboratories 173.37 Bn31.963.7232.61 Bn
3 DHR Danaher Corp /De/ 162.26 Bn40.526.4626.56 Bn
4 ISRG Intuitive Surgical Inc 149.66 Bn47.6813.56-
5 MDT Medtronic plc 120.13 Bn22.973.2028.15 Bn
6 SYK Stryker Corp 113.84 Bn30.534.4114.94 Bn
7 BSX Boston Scientific Corp 65.43 Bn17.803.1212.62 Bn
8 MLAB Mesa Laboratories Inc /Co/ 0.72 Bn150.172.890.14 Bn